Molecular network basis of invasive pituitary adenoma: a review

Q Yang, X Li - Frontiers in endocrinology, 2019 - frontiersin.org
Cases with pituitary adenoma comprise 10–25% of intracranial neoplasm, being the third
most common intracranial tumor, most of the adenomas are considered to be benign. About …

Does the functional polymorphism-1562C/T of MMP-9 gene influence brain disorders?

S Pabian-Jewuła, M Rylski - Frontiers in Cellular Neuroscience, 2023 - frontiersin.org
Metalloproteinase-9 (MMP-9) is one of the most strongly expressed matrix
metalloproteinases (MMPs) in the brain. The MMP-9 activity in the brain is strictly regulated …

How matrix metalloproteinase (MMP)-9 (rs3918242) polymorphism affects MMP-9 serum concentration and associates with autism spectrum disorders: A case-control …

JR Lord, F Mashayekhi, Z Salehi - Development and …, 2022 - cambridge.org
The aim of this project was to evaluate the relationship of matrix metalloproteinase-9 (MMP-
9) genetic variation and its serum concentration with autism spectrum disorder (ASD). One …

Identification of Molecular Mechanisms Responsible for the MMP-9-1562C/T Dependent Differential Regulation of Matrix Metalloproteinase-9 Expression in Human …

S Pabian-Jewuła, M Ambrożek-Latecka… - Genes, 2023 - mdpi.com
The MMP-9-1562C/T polymorphism exerts an impact on the occurrence and progression of
numerous disorders affecting the central nervous system. Using luciferase assays and Q-RT …

MMP-9-1562 C/T single nucleotide polymorphism associates with increased MMP-9 level and activity during papillary thyroid carcinoma progression

J Roncevic, I Djoric, S Selemetjev, J Jankovic… - Pathology, 2019 - Elsevier
Papillary thyroid carcinoma (PTC), a common form of thyroid malignancy, displays
significant variations in clinical features and outcome. The malignant transformation of the …

Expressions of matrix metalloproteinases-9 and tissue inhibitor of metalloproteinase-1 in pituitary adenomas and their relationships with prognosis

H Guo, Z Sun, J Wei, Y Xiang, L Qiu, L Guo… - Cancer biotherapy & …, 2019 - liebertpub.com
Objective: To investigate the expression levels of matrix metalloproteinases-9 (MMP-9) and
tissue inhibitor of metalloproteinase-1 (TIMP-1) in pituitary adenomas (PAs), and to analyze …

[PDF][PDF] Associations of cholesteryl ester transfer protein (CETP) gene variants with pituitary adenoma.

A Sidaraite, R Liutkeviciene… - … Papers of the …, 2020 - biomed.papers.upol.cz
Aim. The aim was to evaluate the association of CETP (rs5882 and rs708272) single
nucleotide polymorphisms with the presence, invasiveness, hormonal activity and …

The role of single-nucleotide polymorphisms in pituitary adenomas tumorigenesis

SS Shah, MK Aghi - Cancers, 2019 - mdpi.com
Pituitary adenomas (PAs) are among the most common intracranial neoplasms, but despite
their histologically benign nature, these tumors sometimes grow large enough to cause …

[HTML][HTML] 精准神经外科学的研究进展

孔梓任, 张笑, 冯时, 弓孟春, 王裕, 马文斌, 王任直 - 科技导报, 2017 - kjdb.org
精准医学, 指根据个体的基因组学, 生活环境, 生活习惯等信息, 对患者进行个体化疾病诊疗和
预防的医学方式. 受益于基因组学, 影像组学的最新成果, 手术, 放疗中新技术的出现 …

Matrix metalloproteinases and their tissue inhibitors as novel markers in invasive pituitary adenomas–a review

J Szydełko, M Litwińczuk, M Szydełko - Journal of Education, Health …, 2019 - apcz.umk.pl
Introduction: Pituitary adenomas are generally benign central nervous system neoplasms
with still increasing prevalence, especially in younger people. According to the recent data …